Michel Vounatsos

Directeur/Membre du Conseil chez REVVITY, INC.

Fortune : 15 M $ au 30/04/2024

62 ans

Health Technology

Consumer Services

Postes actifs de Michel Vounatsos

Sociétés	Poste	Début	Fin
REVVITY, INC.	Directeur/Membre du Conseil	01/03/2020	-
REVVITY, INC.	Independent Dir/Board Member	01/03/2020	-
ZAI LAB LIMITED	Directeur/Membre du Conseil	07/01/2023	-
ZAI LAB LIMITED	Independent Dir/Board Member	07/01/2023	-
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Directeur/Membre du Conseil	06/01/2017	-
	Directeur Général	06/01/2017	-
	Corporate Officer/Principal	18/04/2016	06/01/2017
Biogen GmbH Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.	Directeur/Membre du Conseil	01/01/2017	-
	Directeur Général	-	-
L’Institut de RYthmologie et Modélisation Cardiaque	Président	-	-
L’Institut de RYthmologie et Modélisation Cardiaque	Directeur/Membre du Conseil	-	-
n-Lorem Foundation	Directeur/Membre du Conseil	-	-
Revvity BV Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.	Directeur/Membre du Conseil	-	-

Historique de carrière de Michel Vounatsos

Anciens postes connus de Michel Vounatsos

Sociétés	Poste	Début	Fin
BIOGEN INC.	Directeur/Membre du Conseil	06/01/2017	14/11/2022
	Directeur Général	06/01/2017	14/11/2022
	Corporate Officer/Principal	18/04/2016	06/01/2017
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2008	01/04/2016

Formation de Michel Vounatsos

École des Hautes Études Commerciales de Paris

Masters Business Admin

Statistiques

Internationale

Etats-Unis	6
France	3
Allemagne	2

Opérationnelle

Director/Board Member	8
Chief Executive Officer	3
Corporate Officer/Principal	3

Sectorielle

Health Technology	8
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées	4
BIOGEN INC.	Health Technology
MERCK & CO., INC.	Health Technology
REVVITY, INC.	Health Technology
ZAI LAB LIMITED	Health Technology

Entreprise privées	5
Biogen Idec, Inc. (North Carolina) Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.	Health Technology
Biogen GmbH Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.	Health Technology
L’Institut de RYthmologie et Modélisation Cardiaque
n-Lorem Foundation
Revvity BV Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.	Health Technology

Voir les connexions sociétés